• Explore /
  • Poster
  • / Characteristics and outcome of octogenarian versus young patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) treated with ketoconazole.

Characteristics and outcome of octogenarian versus young patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) treated with ketoconazole.

Abstract Poster

Authors

null

Victoria J. Sinibaldi

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD

Victoria J. Sinibaldi , Michal Dadon-Nachum , Maya Gottfried , Natalie Maimon , Zamir Dovrish , Avivit Peer , Avivit Neumann , Avishay Sella , Svetlana Kovel , Michael Anthony Carducci , Mario A. Eisenberger , Daniel Kejzman

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session B: Prostate, Penile, Urethral, and Testicular Cancers, and Urothelial Carcinoma

Track

Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers

Sub Track

Prostate Cancer

Citation

J Clin Oncol 32, 2014 (suppl 4; abstr 256)

DOI

10.1200/jco.2014.32.4_suppl.256

Abstract #

256

Poster Bd #

E3

Abstract Disclosures

Similar Posters

Poster

2019 Genitourinary Cancers Symposium

Timing of docetaxel chemotherapy and impact on outcomes in metastatic castrate-resistant prostate cancer (MCRPC).

Timing of docetaxel chemotherapy and impact on outcomes in metastatic castrate-resistant prostate cancer (MCRPC).

First Author: Alastair Thomson

First Author: David Thomson

First Author: Ignacio Gil-Bazo

First Author: Jamal Alamiri